Showing results (1-10 of 548) with videos related to
Sort By:
Pageof 55
Statistics in Medicine|October 17, 2023
Handling missing within-study correlations in the evaluation of surrogate endpointsWillem Collier, Benjamin Haaland, Lesley Inker, et al.BMC Medical Research Methodology|February 16, 2024
Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trialsWillem Collier, Benjamin Haaland, Lesley A Inker, et al.JCO Precision Oncology|December 3, 2024
Multigene Copy Number Alteration Risk Score Biomarker-Based Enrichment Study Designs in Metastatic Castrate-Resistant Prostate CancerYeonjung Jo, Jonathan J Chipman, Benjamin Haaland, et al.Statistics in Medicine|July 25, 2019
Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney diseaseEdward Vonesh, Hocine Tighiouart, Jian Ying, et al.Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Randomized Controlled Trials 6: Determining the Sample Size and Power for Clinical Trials and Cohort StudiesTom GreeneMethods in Molecular Biology (Clifton, N.J.)|February 20, 2015
Randomized controlled trials 5: Determining the sample size and power for clinical trials and cohort studiesTom GreeneAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2009
Randomized and observational studies in nephrology: how strong is the evidence?Tom GreeneContributions to Nephrology|May 7, 2005
What did we learn from the HEMO Study? Implications of secondary analysesTom GreeneThe International Journal of Biostatistics|August 2, 2013
A weighting analogue to pair matching in propensity score analysisLiang Li, Tom GreeneClinical Trials (London, England)|October 21, 2011
Statistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trialsGuofen Yan, Tom GreenePageof 55